Recent Finacing
Recent Raise
Paris-based preclinical biotech developing a thiomer biopolymer platform and a 3mm ophthalmic insert that forms an on-eye hydrogel to deliver seven-day controlled drug release for glaucoma and macular edema.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at BIOPHTA.
